Home » Topics » BioWorld Science

BioWorld Science
RSS

Sangstat and Nextran enter marketing agreement

June 14, 1996

EchoGen's safety and efficiency reported

June 14, 1996

rHb1.1 phase I trials begin in end-stage renal disease

June 14, 1996

SC-55494 effective in combination with rhG-CSF

June 14, 1996

CCK-A agonists revealed by Glaxo Wellcome

June 14, 1996

Warner-Lambert seeks approval for atorvastatin

June 14, 1996

Monsanto reveals benzothiazepines with novel activity

June 14, 1996

ACAT inhibitors from Sankyo

June 14, 1996

Hyperlipidemia treatment from Takeda

June 14, 1996

Ligand/Wyeth-Ayerst collaboration extended

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...